The
global Inhalation Anesthesia Market size is projected to
reach USD 1.42 billion by 2025, at a lucrative CAGR of 3.5% over the forecast
period, according to a new report by Grand View Research, Inc. Key factors
contributing to its rapid growth include increasing prevalence of cancer,
cardiovascular, respiratory, neurological, gastrointestinal, orthopedic, and
spinal diseases and disorders.
Furthermore,
increasing number of emergency cases and demand for short stay ambulatory day
care surgical procedure are amongst critical success factors attributed to the
market growth. Access to universal health insurance coverage for a wider
population base coupled with constant improvements in healthcare infrastructure
in various developing countries are expected to positively impact the number of
surgeries performed, thus increasing the usage of inhalation anesthetics.
On
the basis of product, the inhalation anesthesia market is classified into
sevoflurane, isoflurane, and desflurane. These products are used for induction
and maintenance of anesthesia for patients during surgical procedures.
Sevoflurane led the product segment in 2018 and is anticipated to grow at a
lucrative rate over the forecast period, attributed to its therapeutic
advantages, low cost, and higher potency for the induction of anesthesia. On
the other hand, isoflurane is expected to witness the fastest CAGR of 6.3% over
the forecast period, due to its increasing use in maintenance of anesthesia for
treatment of weak or geriatric patients owing to its sparing effect on
cardiovascular function.
On
the basis of regions, the market is broadly classified into North America,
Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North
America held the leading market share of USD 456.0 million and is anticipated
to witness lucrative CAGR over the forecast period. This is owing to increasing
prevalence of chronic diseases coupled with the presence of advanced healthcare
facilities. On the other hand, Asia Pacific was anticipated to witness the
fastest CAGR of 4.0% due to increasing population and number of patients
suffering from chronic population.
Some
of the key players operating in this market include Halocarbon Products
Corporation; Baxter; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co.
Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius
Kabi AG, and AbbVie Inc.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/inhalation-anesthesia-market
https://www.grandviewresearch.com/industry-analysis/inhalation-anesthesia-market
Further key findings from the report suggest:
- Sevoflurane
product segment led the market in terms of revenue, valued at USD 768.6
million, in 2018
- Isoflurane
product segment is anticipated to expand at the fastest CAGR of 6.3% owing
to its increasing use in the treatment of weak and geriatric patients
owing to its low effect on cardiovascular function
- North
America led the market in 2018 with a revenue of USD 456.0 million owing
to the presence of advanced healthcare facilities, strong reimbursement
scenario, and prevalence of chronic diseases
- Key players
operating in the inhalation anesthesia market include Halocarbon Products
Corporation; Baxter; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical
Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co.
Ltd.; Fresenius Kabi AG, and AbbVie Inc.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment